news

2006  |   2004  |   2003  |   2002  |   2001  |   2000  |   1999

2006

Manufacturing Chemist Article [Tues 13-Jun-2006] 
Susan Birk speaks to BAEPD Secretary General, Richard Freudenberg, on parallel importation - Part 1.
http://www.baepd.co.uk/pdf/parallelparadox1.pdf

Manufacturing Chemist Article [Tues 13-Jun-2006] 
2nd part of the Manufacturing Chemist Article.
http://www.baepd.co.uk/pdf/parallelparadox2.pdf

Press Release [Thur 13-Apr-2006] 
Advocate-General announces favourable opinion on repackaging medicines
http://www.baepd.co.uk/pdf/pressreleaseOpinion.pdf

Press Release [Mon 27-Feb-2006] 
Fears that the US market could one day be open to parallel imports are fuelling drug manufacturers attempts to malign the UK parallel distribution industry.
http://www.baepd.co.uk/pdf/pressrelease2006.pdf

2004

Underpinning Patient Safety [Wed 1-Dec-2004] 
Recommendations and Guidelines for product coding within the UK Pharmaceutical Supply Chain. Developed by the Pharmaceutical Industry and Profession in the UK. Representatives from all key areas in the UK pharmaceutical supply chain have come together as a cross-industry working group to discuss and agree on a mutually beneficial strategy that will ultimately deliver improved patient safety and supply chain efficiency. This document is the result of their work.
http://www.baepd.co.uk/pdf/PSCWG.pdf

Appointment of BAEPD new Secretary General [Wed 1-Sep-2004] 
The BAEPD is pleased to announce the appointment of Richard Freudenberg as Secretary General of the association, effective from 1st September 2004.

Press Release - Trademark Case [Mon 8-Mar-2004] 
UK Appeal Court support reboxing rights of Parallel Importers
http://www.baepd.co.uk/pdf/GlaxoDowelhurst.pdf

2003

BAEPD New Member [Tues 29-Jul-2003] 
Stephar (UK) Ltd has joined the BAEPD effective from 1st August 2003.

Press Release - Trademark Case [Tues 22-Jul-2003] 
Press Release following Court Hearing on 11th July 2004 ref. repackagings and use of colour.

Trademark case / examples of repackagings [Fri 18-Jul-2003] 
sereven.jpgAt the Court Hearing on 11th July 2003, the attached packs were deemed non-infringing, including use of colour.

Trademark case / examples of repackagings [Fri 18-Jul-2003] 
flixotide1.gifAt the Court Hearing on 11th July 2003, the attached packs were deemed non-infringing, including use of colour.

Trademark case / examples of repackagings [Fri 18-Jul-2003] 
flixotide2.gifAt the Court Hearing on 11th July 2003, the attached packs were deemed non-infringing, including use of colour.

BAEPD New Member [Mon 5-May-2003] 
GPharma LImited has joined the BAEPD with effect from 1st May 2003

Victory in trademark case [Fri 7-Feb-2003] 
Mr Justice laddie delivered judgement in the Glaxo vs. Dowelhurst case, finding that parallel traders could continue to re-package pharmaceuticals and use UK trademarks to replace the trademark used in the source country if necessary

BAEPD New member [Fri 31-Jan-2003] 
Lexon (UK) Ltd has joined the BAEPD with effect from 27th January 2003

BAEPD rejoin EAEPC [Thur 30-Jan-2003] 
The BAEPD rejoined the EAEPC (European Association of Euro-Pharmaceutical Companies)on December 8th.

This will strengthen the EAEPC and the BAEPD and help to unite the parallel traders throughout Europe.

2002

New BAEPD Secretary General announced [Mon 1-Jul-2002] 
The BAEPD is pleased to announce the appointment of Nick Foster as Secretary General of the association, effective from 8th July 2002.

Importers Victory in ECJ [Sat 1-Jun-2002] 
On 23rd April 2002 the European Court of Justice ("ECJ") delivered a resounding judgement in favour of UK parallel pharmaceutical distributors.

2001

MPA REPORT ON PARALLEL IMPORT LICENCES AND LICENSEES [Mon 1-Jan-2001] 
Parallel import licences granted in 1999, more than double the 1998 figure says Martin Paltnoi Associates.

2000

RECENT DEVELOPMENTS IN THE PARALLEL DISTRIBUTION OF PHARMACEUTICALS WITHIN THE EU [Sat 1-Jul-2000] 
Over the millennium, two significant legal cases were determined, each of which will have impacted positively upon the continued growth of the parallel pharmaceutical distribution industry (PPDI). In mid-December 1999, the European Court of Justice (ECJ) handed down a judgment on Case 94/98 which confirmed that in certain circumstances, if an original product licence has been cancelled at the request of the marketing authorisation holder, the competent regulatory authority is not necessarily obliged to cancel or withdraw any 'piggy-back' licences (e.g. Product Licence (Parallel Import), PL(PI)) which may have been issued to third parties.

BAEPD AND PARANOVA TRAVEL BACK TO UK COURT [Fri 14-Jan-2000] 
On Monday 17th January the major pharmaceuticals repackaging case, Paranova, will be heard in the High Court, following the European Court of Justice decision to refer an important element of the case back to the national court. John Barker, chairman of the British Association of European Pharmaceutical Distributors (BAEPD - formerly known as API), expressed his hope that the judgement would reflect the need to reduce patient confusion over medicines.

Pharmaceutical Distributors repackaged! [Mon 10-Jan-2000] 
Britain's distributors of European pharmaceuticals have announced a major change in their corporate identity. Formerly known as the Association of Pharmaceutical Importers (API), the new organisation is now called the British Association of European Pharmaceutical Distributors (BAEPD).

1999

API initiate judicial review over medicines deal [Tues 16-Nov-1999] 
The Association of Pharmaceutical Importers (API) have won the right to a judicial review of the Pharmaceutical Pricing Review Scheme (PPRS) negotiations held earlier this year.

Letter to Romano Prodi, President of the European Commission, from the API [Mon 19-Jul-1999]

API sceptical about Government medicines deal [Wed 14-Jul-1999] 
Commenting on today's announcement that a 4.5% cut in pharmaceutical prices has been agreed between the government and industry as a renegotiation of the PPRS (Pharmaceutical Pricing Review Scheme)

The HoC Trade & Industry Select Committee: status summary [Tues 11-May-1999] 
Trade Marks and Competition.

Letter to Frank Dobson from the API following his speech at the ABPI dinner [Fri 7-May-1999] 
Letter to:



Rt Hon Frank Dobson MP
Secretary of State for Health

THE API REPACKAGING OF PHARMACEUTICAL PRODUCTS: PARANOVA [Mon 4-Jan-1999] 
Historically, when medicinal products have ben procured from other EU member states for delivery into the pharmaceutical supply chain within the United Kingdom, the distributor in order to comply with the terms of the relevant Product Licence granted to him by the Medicines Control Agency as well as to ensure compliance with the appropriate labelling regulations has, at the very minimum, applied a "sticker" to both the outer carton as well to the blister containing the tablets/capsules.

The future for the Pharmaceutical Wholesaling Industry [Sun 3-Jan-1999] 
by Paracelsius

Focus on Parallel Trade [Sat 2-Jan-1999] 
Overall PI Penetration Nears 2%

Seeking Co-habitation with Industry, John Barker of the API [Fri 1-Jan-1999] 
After 12 years involvement in parallel importing in the United Kingdom, first as a distributor and then as the chairman of the national body, the Association of Pharmaceutical Importers (API), John Barker has had many dealings with pharmaceutical manufacturers. Much of the dialogue has been tense, some has ended up with both parties facing each other in court. A softening of this attitude is now evident. Only last month, Mr Barker sat round the same table as the industry group, the ABPI, it may have been to discuss the Y2K issue, but it nevertheless marked the first ever ABPI/API collaboration.

The API's written evidence to the DTI consultation on e-commerce [Fri 1-Jan-1999] 
The Government is currently considering the needs and regulation of electronic commerce. The API sent the following document as its response to the recent consultative document, 'Building Confidence in Electronic Commerce' (URN99/642). The Trade and Industry Committee in its Seventh Report for session 1998/9 (HC187) acknowledges the significance of the API response.

The British Association of European Pharmaceutical Distributors
registered number: 01801727
All contents © BAEPD

   Chingford, London E4 7DL
   +44 (0)20 8529 3646
   +44 (0)20 8529 2464
   admin@baepd.co.uk